Nov 07 ASAM welcomes new CMS Direction on Section 115 Waivers
From ASAM – The American Society of Addiction Medicine (ASAM) commends CMS’ recent guidance to State Medicaid Directors on section 1115(a) demonstrations “designed to improve quality of and access to treatment for addiction.” This new guidance expands access to care and requires states to align their section 1115(a) demonstrations with certain goals and evidence-based milestones.
ASAM President and CleanSlate CMO Dr. Kelly J. Clark had this to say about the new guidance: “It’s important that people get the right care, in the right place, and at the right time by using evidence-based criteria such as The ASAM Criteria. This new policy goes a long way toward ensuring that patients can feel confident that the kind of treatment recommended and being received is consistent with good medical care standards. We look forward to working with Congress, the administration, and our partners at the state and local levels to ensure that funding is utilized in the most efficient and effective way to combat this epidemic.”